Page 33 - Read Online

Quartuccio et al. J Cancer Metastasis Treat 2021;7:14 I http://dx.doi.org/10.20517/2394-4722.2020.118 Page 13 of 13

18
27. Piccardo A, Trimboli P, Puntoni M, et al. Role of F-Choline Positron Emission Tomography/Computed Tomography to Detect Structural
Relapse in High-Risk Differentiated Thyroid Cancer Patients. Thyroid 2019;29:549-56.
28. Poisson T, Deandreis D, Leboulleux S, et al. 18F-fluorodeoxyglucose positron emission tomography and computed tomography in
anaplastic thyroid cancer. Eur J Nucl Med Mol Imaging 2010;37:2277-85.
29. Qiu ZL, Xue YL, Song HJ, Luo QY. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy,
131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer. Nucl Med Commun
2012;33:1232-42.
30. Sakurai Y, Kawai H, Iwano S, Ito S, Ogawa H, Naganawa S. Supplemental value of diffusion-weighted whole-body imaging with
background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases
from thyroid cancer. J Med Imaging Radiat Oncol 2013;57:297-305.
31. Shinto AS, Kamaleshwaran KK, Mallia M, et al. Utility of (99m)Tc-Hynic-TOC in 131I Whole-Body Scan Negative Thyroid Cancer
Patients with Elevated Serum Thyroglobulin Levels. World J Nucl Med 2015;14:101-8.
32. IntHout J, Ioannidis JP, Borm GF, Goeman JJ. Small studies are more heterogeneous than large ones: a meta-meta-analysis. J Clin
Epidemiol 2015;68:860-9.
33. Vrachimis A, Burg MC, Wenning C, et al. [(18)F]FDG PET/CT outperforms [(18)F]FDG PET/MRI in differentiated thyroid cancer. Eur J
Nucl Med Mol Imaging 2016;43:212-20.
34. Vrachimis A, Stegger L, Wenning C, et al. [(68)Ga]DOTATATE PET/MRI and [(18)F]FDG PET/CT are complementary and superior
to diffusion-weighted MR imaging for radioactive-iodine-refractory differentiated thyroid cancer. Eur J Nucl Med Mol Imaging
2016;43:1765-72.